Erratum. Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1). Diabetes Care 2014;37:2159-2167
- PMID: 26106226
- DOI: 10.2337/dc15-er07b
Erratum. Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1). Diabetes Care 2014;37:2159-2167
Erratum for
-
Efficacy and safety of dulaglutide added onto pioglitazone and metformin versus exenatide in type 2 diabetes in a randomized controlled trial (AWARD-1).Diabetes Care. 2014 Aug;37(8):2159-67. doi: 10.2337/dc13-2760. Epub 2014 May 30. Diabetes Care. 2014. PMID: 24879836 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
